80 related articles for article (PubMed ID: 8296141)
1. [Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases].
Germaud P; Poirier J; Jacqueme P; Guerin JC; Benard Y; Boutin C; Brambilla C; Escamilla R; Zuck P
Rev Pneumol Clin; 1993; 49(3):137-41. PubMed ID: 8296141
[TBL] [Abstract][Full Text] [Related]
2. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Oh HM; Ng AW; Lee SK
Singapore Med J; 1996 Jun; 37(3):255-7. PubMed ID: 8942221
[TBL] [Abstract][Full Text] [Related]
3. [Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
Sánchez ME; Gómez J; Gómez Vargas J; Baños V; Ruiz Gómez J; Muñoz L; Simarro E; Soto MC; Canteras M; Valdés M
Rev Esp Quimioter; 1998 Jun; 11(2):132-8. PubMed ID: 9795298
[TBL] [Abstract][Full Text] [Related]
4. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
5. [A new therapeutic strategy using a ofloxacin-amoxicillin-clavulanic acid combination in the treatment of upper gynecologic infections. Apropos of 123 cases].
Verhoest P; Fernandez H; Henry-Suchet J; Orfila J; Boulanger JC
J Gynecol Obstet Biol Reprod (Paris); 1994; 23(1):39-46. PubMed ID: 8157889
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of ciprofloxacin versus amoxicillin + clavulanic acid or erythromycin for the empiric treatment of community-acquired pneumonia].
Mouton Y; Beuscart C; Leroy O; Ajana F; Charrel J
Pathol Biol (Paris); 1991 Jan; 39(1):34-7. PubMed ID: 2011407
[TBL] [Abstract][Full Text] [Related]
7. [Amoxicillin associated with clavulanic acid. Clinical efficacy and tolerance].
Lazzati M; Coppola D; Silvestri A; Introini L; Macchi R; Castoldi A
Dent Cadmos; 1990 Mar; 58(5):40-8. PubMed ID: 2397838
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
Tassler H
Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
[TBL] [Abstract][Full Text] [Related]
9. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Lim TK
Singapore Med J; 1997 Mar; 38(3):139. PubMed ID: 9269388
[No Abstract] [Full Text] [Related]
10. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
11. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R
Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
[TBL] [Abstract][Full Text] [Related]
12. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid.
Brook I; Foote PA; Hausfeld JN
Int J Antimicrob Agents; 2005 Nov; 26(5):416-9. PubMed ID: 16226017
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
[TBL] [Abstract][Full Text] [Related]
14. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes.
Wang JL; Chen KY; Fang CT; Hsueh PR; Yang PC; Chang SC
Clin Infect Dis; 2005 Apr; 40(7):915-22. PubMed ID: 15824979
[TBL] [Abstract][Full Text] [Related]
15. [Amoxicillin in association with clavulanic acid in the treatment of urinary infection in children].
Roca i Martínez J; Durán Bellido M; Suris i Granell JC; Iglesias Salvador D; Hidalgo Ibáñez MJ; Juncosa Morros T; Latorre Otín C
An Esp Pediatr; 1990 Jan; 32(1):53-7. PubMed ID: 2327665
[TBL] [Abstract][Full Text] [Related]
16. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of pristinamycin vs amoxicillin in community acquired pneumonia in adults].
Trémolières F; Mayaud C; Mouton Y; Weber P; Dellatolas F; Caulin E
Pathol Biol (Paris); 2005; 53(8-9):503-10. PubMed ID: 16181747
[TBL] [Abstract][Full Text] [Related]
19. Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults.
Garau J; Twynholm M; Garcia-Mendez E; Siquier B; Rivero A;
J Antimicrob Chemother; 2003 Nov; 52(5):826-36. PubMed ID: 14563899
[TBL] [Abstract][Full Text] [Related]
20. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
Powers RD
Am J Med; 1993 Mar; 94(3A):155S-158S. PubMed ID: 8452173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
